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Vascular risk factors and cerebral blood flow (CBF) reduction have been linked to
increased risk of cognitive impairment and Alzheimer’s disease (AD); however the
possible moderating effects of age and vascular risk burden on CBF in late life remain
understudied. We examined the relationships among elevated vascular risk burden,
age, CBF, and cognition. Seventy-one non-demented older adults completed an arterial
spin labeling MR scan, neuropsychological assessment, and medical history interview.
Relationships among vascular risk burden, age, and CBF were examined in a priori regions
of interest (ROIs) previously implicated in aging and AD. Interaction effects indicated
that, among older adults with elevated vascular risk burden (i.e., multiple vascular risk
factors), advancing age was significantly associated with reduced cortical CBF whereas
there was no such relationship for those with low vascular risk burden (i.e., no or
one vascular risk factor). This pattern was observed in cortical ROIs including medial
temporal (hippocampus, parahippocampal gyrus, uncus), inferior parietal (supramarginal
gyrus, inferior parietal lobule, angular gyrus), and frontal (anterior cingulate, middle frontal
gyrus, medial frontal gyrus) cortices. Furthermore, among those with elevated vascular
risk, reduced CBF was associated with poorer cognitive performance. Such findings
suggest that older adults with elevated vascular risk burden may be particularly vulnerable
to cognitive change as a function of CBF reductions. Findings support the use of
CBF as a potential biomarker in preclinical AD and suggest that vascular risk burden
and regionally-specific CBF changes may contribute to differential age-related cognitive
declines.
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INTRODUCTION
Vascular risk factors increase risk of cognitive impairment and
Alzheimer’s disease (AD) (Luchsinger et al., 2005; Gorelick et al.,
2011). Although it is known that the link between vascular risk
and cognitive decline is independent of clinical stroke (Gorelick
et al., 2011) and vascular brain lesions imaged with magnetic res-
onance imaging (MRI) (Zheng et al., 2012), how vascular risk
might lead to increased risk of AD has yet to be determined.
According to the “two-hit vascular hypothesis” of AD (Zlokovic,
2011), vascular risk factors may lead to blood–brain barrier (BBB)
dysfunction and reduced cerebral blood flow (CBF), initiating
a cascade of processes that lead to dementia. In the primary
(non-amyloid-β) pathway (hit one), accumulation of neurotoxic
molecules and capillary hypoperfusion lead to neuronal dysfunc-
tion. Vascular dysfunction also leads to increased production
and decreased clearance of amyloid-β, leading to amyloid-β
accumulation. This increase in amyloid-β (hit two) leads to fur-
ther neuronal dysfunction, accelerating neurodegeneration, and
the development of dementia. Both amyloid-β and hypoperfu-
sion may increase hyperphosphorylation of tau thereby leading
to neurofibrillary tangle formation. Vascular-mediated neuronal
dysfunction may be particularly relevant for very-old adults (i.e.,
those over age 80) given that arterial stiffness and vascular dis-
orders are more common and more severe in this age group (De
Leeuw et al., 2001).
Evidence from neuropathologic studies suggest that the pres-
ence of cerebrovascular disease (CVD) may lower the threshold
of AD pathology accumulation necessary to clinically unmask
dementia (Chui et al., 2012). AD patients with comorbid CVD
show less AD pathology than AD patients without CVD (Esiri
et al., 1999), even when patients with and without CVD are iden-
tical in terms of level of dementia severity (Bangen et al., in press).
Frontiers in Aging Neuroscience www.frontiersin.org July 2014 | Volume 6 | Article 159 | 1
AGING NEUROSCIENCE
Bangen et al. Vascular risk, aging, and CBF
The association between AD pathology and dementia is attenu-
ated among very-old adults (Prohovnik et al., 2006; Savva et al.,
2009) and neuropathologic studies show a greater prevalence
of mixed pathology with both AD and vascular features along
with fewer cases of “pure” AD pathology among the oldest-old
(Jellinger and Attems, 2010). Taken together, these studies sug-
gest that vascular dysfunction is an important mechanism leading
to cognitive impairment (Pantoni, 2010), and may play an even
more prominent role among very-old adults.
Arterial spin labeling (ASL)MRI has been employed to reliably
measure CBF across the aging-MCI-AD continuum (Johnson
et al., 2005; Restom et al., 2007; Bangen et al., 2009). Abnormal
resting state CBF may be an early indicator of brain dysfunc-
tion in individuals at risk for developing dementia (Fleisher et al.,
2009; Bangen et al., 2012; Wierenga et al., 2012). ASL stud-
ies of dementia and at-risk populations demonstrate patterns
of regional hypoperfusion similar to those revealed by positron
emission tomography (PET) and single photon emission com-
puted tomography (SPECT) (Detre and Alsop, 1999; Alsop et al.,
2000). Advantages of ASL over PET and SPECT include the use of
an endogenous tracer (rather than an intravenously administered
contrast agent), relatively brief scan times (typically 5–10min),
and the ability to provide dynamic CBF estimates (with a tempo-
ral resolution on the order of seconds) due to the rapid decay of
the tracer (Johnson et al., 2005). Given these factors, ASL MRI
may provide a sensitive technique for identifying at-risk indi-
viduals, monitoring changes in neural activity due to developing
neuropathology, and assessing effectiveness of disease-modifying
treatments.
Although associations have been consistently found between
aging and hypoperfusion and between vascular risk factors and
hypoperfusion (Grolimund and Seiler, 1988; Bangen et al., 2009;
Muller et al., 2012), the interaction between advanced age and vas-
cular risk burden on CBF remains unclear. Furthermore, most
studies have focused on individual vascular risk factors, how-
ever, multiple vascular risk factors often co-exist (Genest and
Cohn, 1995) and have been shown to incrementally increase risk
for AD (Luchsinger et al., 2005; Whitmer et al., 2005). Studies
often examine individual risk factors while adjusting for addi-
tional risk factors, but this approach may lead to over-adjustment
and underestimation of effects (Szklo andNieto, 2000; Luchsinger
et al., 2005). Our previous research demonstrated that aggregate
vascular risk in particular was associated with CVD in a sam-
ple of autopsy-confirmed AD patients, highlighting the potential
importance of aggregate risk in the vascular contribution to
cognitive impairment (Bangen et al., in press).
Therefore, the present study aimed to elucidate the rela-
tionships among elevated vascular risk burden, age, CBF, and
cognition. We predicted that the presence of elevated vascular
risk burden (i.e., multiple vascular risk factors) would interact
with advancing age to result in reduced CBF. CBF was mea-
sured in regions of interest (ROIs) that were selected based on
previous results suggesting their vulnerability to small vessel dis-
ease and association with AD and aging. We further predicted
that reduced CBF in specific ROIs would correlate with poorer
neuropsychological performance in associated cognitive domains
[e.g., reduced CBF in medial temporal (MTL) regions would be
associated with poorer memory]. Finally, we predicted that, those
older adults with elevated vascular risk burden would be par-
ticularly vulnerable to cognitive change as a function of CBF
reduction. Such findings may improve detection of individu-
als at risk for cognitive impairment and may help inform the
development of treatments designed to slow or prevent cognitive
decline.
MATERIALS AND METHODS
PARTICIPANTS
Seventy-one independently living, non-demented older adults
were recruited from the San Diego community and ongoing
studies at the University of California San Diego (UCSD) Shiley-
Marcos Alzheimer’s Disease Research Center (ADRC). Potential
participants were excluded if they were younger than 65 years
of age; had dementia identified by medical, neurological, and
neuropsychological examinations; or had a history of neurologic
disease, head injury with loss of consciousness, learning disabil-
ity, or major psychiatric disorder. Of the 71 participants, two
had three vascular risk factors (hypertension, diabetes, cardio-
vascular disease, atrial fibrillation, history of transient ischemic
attack [TIA]/minor stroke, or current smoking), 14 had two vas-
cular risk factors, 33 had one vascular risk factor and 22 had
none. For analytical purposes, those with multiple (i.e., two or
three) vascular risk factors were collapsed into one category and
compared to those with no or one vascular risk factor. Thus,
we compared higher and lower vascular risk burden groups. All
data were collected in accordance with UCSD and VA San Diego
Healthcare System institutional review board-approved proce-
dures and within the guidelines of the Helsinki Declaration.
All participants provided written informed consent prior to
enrollment.
CLINICAL AND NEUROPSYCHOLOGICAL ASSESSMENT
All participants underwent a semi-structured interview regard-
ing medical and psychiatric history; neurological examination;
assessment of functional abilities; physical examination with
brachial artery blood pressure measurement using an automated
blood pressure cuff; neuropsychological testing; buccal swabDNA
extraction for APOE genotyping; and brain MRI. The presence
or absence of vascular risk factors derived from the Framingham
Stroke Risk Profile (D’Agostino et al., 1994) was determined
by self-report, medical chart review, and physical examination.
Targeted vascular risk factors included: (1) hypertension; (2) dia-
betes; (3) history of cardiovascular disease (e.g., coronary artery
disease (myocardial infarction, angina pectoris, coronary insuf-
ficiency), intermittent claudication, cardiac failure); (4) atrial
fibrillation; (5) TIA or minor stroke; and (6) current smoking.
Hypertension was defined as systolic blood pressure ≥ 140mm
Hg, diastolic blood pressure≥ 90mmHg, or use of antihyperten-
sive medications. Each vascular risk factor was assigned a value
of 0 if absent and 1 if present. Global cognition was assessed by
the Dementia Rating Scale (DRS) (Mattis, 1988), episodic mem-
ory was assessed by the California Verbal Learning Test-Second
Edition (CVLT-II) (Delis et al., 2000), and executive functioning
was assessed by Part B of the Trail Making Test (one participant
in the high vascular risk group did not complete the Trail Making
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Test). APOE genotype was determined using a polymerase chain
reaction-based method (Saunders et al., 1993).
MRI ACQUISITION
Participants were scanned on a GE Signa HDx 3.0 Tesla whole
body MR scanner using an 8-channel receive-only head coil
(General Electric Medical Systems, Milwaukee, WI, USA). A T1-
weighted anatomical scan was acquired at 1mm3 resolution using
either a 3D MPRAGE sequence (26 cm FOV, 256 × 256 matrix,
TR = 7ms, TE = 3ms, flip angle = 8◦, inversion time = 900ms,
bandwidth = 31.25 kHz, and 170 1.2mm sagittal slices) or a 3D
FSPGR sequence (identical parameters to MPRAGE except 25 cm
FOV, 256 × 192 matrix, TR = 8.1ms, inversion time = 600ms,
172 1mm sagittal slices). T2-weighted fluid attenuated inver-
sion recovery (FLAIR) images (20 cm FOV, 256 × 256 matrix,
flip angle = 90◦, TE = 142ms, TR = 10000ms, 5mm axial slices
with no interslice gap) were acquired for a subset of 41 par-
ticipants (35 with low and 6 with high vascular risk burden).
A resting state pulsed ASL scan was acquired using a modi-
fied flow-sensitive alternating inversion recovery sequence (Kim,
1995) [post-saturation and inversion times of TI1 = 600ms and
TI2 = 1600ms, TR = 2500ms, TE = 3.2ms FOV = 22 × 22 cm,
64 × 64 matrix, 20 5mm axial slices, 40 volumes (20 tag+control
image pairs)]. This sequence utilized presaturation pulses and
PICORE QUIPSS 2 post-inversion saturating pulses and a spi-
ral read out with four interleaves (Wong et al., 1998). A scan
with the inversion pulses turned off was acquired to obtain an
estimate of the magnetization of cerebrospinal fluid (CSF). The
CSF signal was used to estimate the equilibriummagnetization of
blood, which was used to convert the perfusion signal into cal-
ibrated CBF units (millimeters of blood per 100 g of tissue per
minute) (Chalela et al., 2000). In addition, a minimum contrast
scan was acquired to adjust for coil inhomogeneities during the
CBF quantification step (Wang et al., 2005).
MRI DATA PROCESSING
MRI data were processed using Analysis of Functional
NeuroImages (AFNI) (Cox, 1996), FMRIB Software Library
(FSL) (Smith et al., 2004), and locally created MATLAB scripts.
T1-weighted anatomical images
Following N3 bias correction of field inhomogeneities, structural
scans were skull-stripped using Brain Surface Extractor (Version
3.3) (Shattuck et al., 2001), an approach shown to be very
effective when working with the images of older adults (Fennema-
Notestine et al., 2006). Scans were manually edited when neces-
sary to remove any residual non-brain material remaining after
the automated skull stripping. Whole brain images were then seg-
mented into gray matter (GM), white matter (WM), and CSF
compartments using FSL’s FMRIB’s Automated Segmentation
Tool (FAST) (Zhang et al., 2001). High-resolution anatomical
images and partial volume segmentations were registered to ASL
space and down-sampled to the resolution of the ASL image using
AFNI.
T2-weighted FLAIR images
Although CBF is of primary interest, we assessed white matter
lesions (WML) given evidence linking them to advanced aging
and vascular risk (Raz et al., 2012). For quantification of WML
volume, we applied a semiautomated volumetric approach to
T2-FLAIR images using a reliable, previously published method
(Delano-Wood et al., 2008). This type of semi-automated volu-
metric approach is a methodology shown to be the most reliable
approach for the analysis of WMLwhen compared to other image
types and traditional quantitative visual rating scales (Price et al.,
2005). Briefly, using AFNI, circumscribed areas of increased sig-
nal intensity within theWMweremanually traced in 17–21 image
slices per participant in the axial plane. WML volume was quan-
tified as the total number of voxels (mm3) of these hyperintense
regions.
ASL images
Each ASL dataset was reconstructed using the SENSE algorithm
(Pruessmann et al., 1999). To minimize effects of participant
motion, the ASL time series was co-registered to the middle time-
point. A mean ASL image was formed for each participant from
the average difference of control and tag images using surround
subtraction. Slice timing delays were accounted for to ensure the
inversion time (TI2) was slice specific (Liu and Wong, 2005).
The mean ASL image was converted to absolute units of CBF
(milliliters per 100 g of tissue per minute) using the CSF image
as a reference signal (Chalela et al., 2000). To correct CBF data
partial volume effects and minimize the effects on the CBF esti-
mates of the lower perfusion in WM and the lack of perfusion in
CSF, we used a previously published method that assumes that
CSF has zero CBF and that CBF in GM is 2.5 times greater than in
WM (Johnson et al., 2005). Partial-volume-corrected CBF signal
intensities were calculated using the following formula: CBFcorr =
CBFuncorr/(GM + 0.4 ∗ WM). CBFcorr and CBFuncorr are cor-
rected and uncorrected CBF values, respectively. GM and WM
are GM and WM partial volume fractions, respectively, and were
computed based on the tissue content of each perfusion voxel
as determined by FSL’s FAST program. The CBFcorr data were
spatially smoothed to a resolution of 4mm full-width at half-
maximum. CBF voxels with negative intensities were replaced
with zero (Brown et al., 2003). In addition, we used a conserva-
tive threshold that removed CBF values outside of the expected
physiological range of CBF (below 10 or greater than 150) from
analyses. CBF data were normalized to the atlas of Talairach and
Tournoux (1988) and re-sampled at a 4mm3 resolution.
STATISTICAL ANALYSES
Demographic and clinical data
Independent samples t-tests for continuous variables and χ2 tests
for categorical variables were used to compare the participant
groups on demographic and clinical variables.
Neuroimaging data
ROI analyses for the CBF data included two subcortical and
four cortical regions defined in AFNI using the Talairach atlas.
The two subcortical ROIs, caudate and thalamus, were selected
because of their vulnerability to small vessel disease. The four
cortical ROIs were MTL (hippocampus, parahippocampal gyrus,
uncus), inferior parietal (supramarginal gyrus, inferior parietal
lobule, angular gyrus), posteromedial (posterior cingulate, pre-
cuneus, cuneus), and frontal (anterior cingulate, middle frontal
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gyrus, medial frontal gyrus) cortices. These four cortical regions
were selected because MTL, inferior parietal, and posteromedial
cortices have been implicated in early AD, and frontal lobe has
been associated with aging and elevated vascular risk. The average
quantified CBF corrected for partial volume effects was extracted
for each of the six ROIs. Hierarchical multiple regression anal-
yses were performed to investigate the interaction between age
and vascular risk burden (high and low) in each ROI. All mod-
els included sex and APOE ε4 status (ε4 carrier or non-carrier)
as covariates in the first block, main effects of age and vascular
risk burden in the second block, and age by vascular risk burden
interaction terms in the third block.
Associations between cognitive performance and CBF in ROIs
with significant interactions between age and vascular risk bur-
den were examined for each subgroup (high and low vascular risk
burden) with bivariate correlations. Performance on the CVLT-
II (List A Trials 1–5 raw score) was correlated with CBF in MTL
and posteromedial ROIs given the role of these regions in episodic
memory. Performance on Part B of the Trail-Making Test (total
time raw score) was correlated with CBF in frontal and pari-
etal ROIs given the role of these regions in executive functioning
and visual attention/spatial cognition/visuomotor integration.
Significance levels of 0.05 were used for all tests. All analyses were
performed using SPSS (version 18.0).
RESULTS
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS
Participants with low and high vascular risk burden did not
significantly differ in terms of mean age, years of education,
sex distribution, global cognitive functioning as assessed by
the DRS, depressive symptomatology, or APOE genotype (all
p-values > 0.05; Table 1). As expected, the group with high vas-
cular risk burden had significantly greater frequencies of many of
the vascular risk factors including hypertension, diabetes, cardio-
vascular disease, and history of TIA or clinical stroke. In addition,
compared to those with low vascular risk burden, they had signif-
icantly reduced diastolic blood pressure, which may result from
atherosclerosis and arterial stiffening (Qiu et al., 2005), and they
were also more likely to be taking anti-hypertensive medication
(see Table 1).
CEREBRAL BLOOD FLOW: INTERACTION OF VASCULAR RISK BURDEN
AND AGE
Figure 1 displays the average quantified CBF (corrected for partial
volume effects) in each of the four cortical ROIs as a function of
age and vascular risk burden. Multiple regression analyses showed
that, after adjusting for sex and APOE ε4 status, there were signif-
icant interactions between age and vascular risk burden for the
MTL (R2 = 0.07, B = −0.86, p = 0.02), inferior parietal (R2 =
0.07, B = −1.05, p = 0.02), and frontal ROIs (R2 = 0.11, B =
−0.66, p = 0.002) and a trend toward a significant interaction
for the posteromedial ROI (R2 = 0.03, B = −0.63, p = 0.12).
As illustrated in Figure 1, the interaction effects were charac-
terized by a negative relationship between age and CBF in the
high vascular risk burden group but no such relationship in the
low vascular risk burden group. Follow up bivariate correlational
analyses were conducted for those with low and high vascular risk
burden separately. These follow up analyses demonstrated that,
among those with high vascular risk burden, aging was associ-
ated with significantly reduced CBF or trends toward significantly
reduced CBF across all four ROIs (MTL CBF: r = −0.49, p =
0.06; Posteromedial CBF: r = −0.46, p = 0.08; Inferior parietal
Table 1 | Demographic and clinical characteristics of participants.
Low vascular risk Mean (SD) High vascular risk Mean (SD) t or χ2 P
N 55 16
Age (years) 74.73 (7.92) 75.94 (7.35) 0.55 0.59
Education (years) 16.31 (2.41) 15.13 (2.03) 1.79 0.08
Women/men (% Women) 33/22 (60.0%) 8/8 (50.0%) 0.51 0.48
APOE ε4 carrier/non-carrier (% ε4 carrier)* 16/37 (29.1%) 9/7 (56.3%) 3.61 0.06
DRS total score 139.82 (3.94) 139.56 (4.50) 0.22 0.83
CVLT-II trials 1–5 total (T -score) 46.43 (11.87) 46.13 (11.74) 0.43 0.67
Trails B (s) 80.57 (29.81) 78.67 (34.19) 0.21 0.83
Geriatric depression scale 3.40 (3.82) 4.27 (3.54) 0.79 0.43
Systolic blood pressure 129.16 (16.21) 130.06 (12.45) 0.21 0.84
Diastolic blood pressure 77.05 (9.30) 71.31 (8.26) 2.23 0.03
Use of antihypertensive medications, n (%) 23 (41.8%) 14 (87.5%) 10.39 0.006
Hypertension, n (%) 27 (49.1%) 15 (93.8%) 10.23 0.001
Diabetes, n (%) 1 (1.8%) 4 (25%) 10.18 0.001
Cardiovascular disease, n (%) 0 7 (43.8%) 26.69 <0.001
History of atrial fibrillation, n (%) 3 (5.5%) 3 (18.8%) 2.83 0.09
Current smoker, n (%) 2 (3.6%) 0 0.60 0.44
History of TIA or stroke, n (%) 0 5 (31.3%) 18.49 <0.001
SD, standard deviation; APOE, apolipoprotein E; DRS, Mattis Dementia Rating Scale; CVLT-II, California Verbal Learning Test-Second Edition.
*Two participants with low vascular risk factors burden were missing APOE genotype data.
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FIGURE 1 | Interaction of age and vascular risk burden on cerebral
blood flow (CBF) for four a priori cortical regions of interest.
Interactions were statistically significant for the medial temporal, inferior
parietal, and frontal regions of interest (p-values < 0.05) and there was a
trend toward an interaction for posteromedial CBF (p = 0.12). High
vascular risk indicates the presence of two or more vascular risk factors
whereas low vascular risk indicates the presence of no or one vascular
risk factor.
CBF: r = −0.48, p = 0.06; Frontal CBF: r = −0.59, p = 0.01).
In contrast, among those with low vascular risk burden, there
were no significant associations or trends toward significant asso-
ciations between age and CBF (MTL CBF: r = 0.10, p = 0.45;
Posteromedial CBF: r = −0.07, p = 0.60; Inferior parietal CBF:
r = −0.02, p = 0.89; Frontal CBF: r = 0.17, p = 0.21). There
were no significant interactions between age group and vascular
risk status for the two subcortical regions: thalamus (R2 = 0.02,
B = −0.75, p = 0.18) and caudate (R2 = 0.008, B = −0.28, p =
0.42). There were no main effects of age or vascular risk sta-
tus on CBF across any of the six ROIs (p-values > 0.05 see
Table 2).
In the subset of participants with T2-FLAIR imaging, hierar-
chical regression models adjusting for sex and APOE ε4 status
showed that there was no interaction between age and vascular
risk burden on total WML volume (R2 = 0.005, B = −139.19,
p = 0.54). Furthermore, there was no main effect of vascular risk
burden on total WML volume (B = −1211.40, p = 0.48). There
was, however, a main effect of age, with advancing age associ-
ated with greater total WML volume (β = 0.32, p = 0.02). WML
volume was not significantly correlated with CBF in any ROI
(p-values> 0.05).
ASSOCIATION BETWEEN CBF AND COGNITION
As shown in Figure 2, among those with high vascular risk bur-
den, reduced CBF in inferior parietal (r = −0.77, p < 0.001)
and frontal (r = −0.72, p = 0.001) ROIs was associated with
poorer performance on an executive functioning measure requir-
ing visual attention, spatial perception, and visuomotor integra-
tion. Also, among this group, there was a trend toward reduced
CBF in MTL being associated with poorer memory perfor-
mance (r = 0.31, p = 0.13). Among those with low vascular risk
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burden, although there was a trend toward a significant associa-
tion between inferior parietal CBF and Trails B performance (r =
0.19, p = 0.09), there were no significant relationships between
cognitive performance and CBF in this group (frontal CBF and
Trails B: r = 0.10, p = 0.24; MTL CBF and CVLT: r = −0.13,
p = 0.17).
DISCUSSION
The present study extends previous cerebral perfusion studies of
dementia risk by demonstrating an interaction between advanc-
ing age and vascular risk burden on CBF. We found that, among
those with elevated vascular risk burden, advancing age was asso-
ciated with reduced CBF, whereas for the low vascular risk burden
group, there was no such relationship.
This pattern was observed for cortical ROI that have been
implicated in aging and AD, namely, MTL, inferior parietal, and
frontal cortices. In addition, reduced CBF was associated with
poorer cognitive performance in participants with elevated vascu-
lar risk burden, and this relationship was not seen in participants
with low vascular risk burden, suggesting that older adults with
multiple vascular risk factors may be particularly vulnerable to
cognitive change as a function of CBF reduction.
Regional decreases in CBF have often been interpreted as a
reflection of decreased brain function whereas increases in per-
fusion have frequently been interpreted as a cellular and vascular
compensatory response to pathologic changes (Dai et al., 2009;
Bangen et al., 2012; Wierenga et al., 2012). It has been suggested
that advancing age increases risk for dementia via its tendency to
reduce CBF (De La Torre, 2012a,b). Studies have reported that
aging may account for an approximately 0.45–0.50% reduction in
CBF per year (Leenders et al., 1990; Parkes et al., 2004). Therefore,
the presence of vascular risk factors may add to the already dimin-
ished CBF that results from aging and these two burdens on
CBF could decrease neuronal energy thereby leading to cognitive
decline (De La Torre, 2012a). The findings of the present study
suggest that the presence of multiple vascular risk factors and
advanced age interact to impart more detrimental effects on CBF
than either one alone.
Among those with high vascular risk burden, younger age was
associated with higher CBF. In addition, greater CBF in frontal
and posterior regions was associated with better executive func-
tion among those with elevated vascular risk. Taken together,
these findings raise the possibility that elevated CBF may rep-
resent a compensatory mechanism in this group. It is possible
that older adults with multiple vascular risk factors are able to
invoke compensatory mechanisms at younger ages. However, as
they age, they may have less capacity for compensation given that
their brain perfusion may be already reduced due to advanced
age. Burgeoning evidence suggests that cerebral autoregulation
is unlikely to reverse brain hypoperfusion if cardiac output is
compromised (De La Torre, 2012a). Therefore, the presence of
cardiovascular pathology in older adults may have long-term
effects on CBF because it may limit neuronal responses from
being able to maintain normal regulatory and/or compensatory
capabilities.
The present findings are consistent with our previous reports
suggesting that multiple dementia risk factors interact to reduce
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FIGURE 2 | Scatterplots of correlations between cerebral blood flow and
cognitive performance for older adults with elevated vascular risk
burden. (A) Correlation between memory performance and medial temporal
lobe cerebral blood flow (p = 0.13), (B) Correlation between executive
function performance and frontal cerebral blood flow (p = 0.001), and
(C) Correlation between executive function performance and inferior parietal
cerebral blood flow (p < 0.001). Higher scores on Trails B represent poorer
(slower) performance.
CBF in regions vulnerable to early AD and aging (Wierenga
et al., 2012) and may be valuable for characterizing changes
in structure-function relationships in individuals at risk. We
observed interactions between age and vascular risk burden on
CBF in cortical regions implicated in early AD or aging (Braak
and Braak, 1991, 1996; Raz et al., 1997; McDonald et al., 2009),
but no interactions in subcortical regions. Notably, amyloid bur-
den has been shown to increase over time in non-demented older
adults in the posterior cingulate, frontal, parietal, and tempo-
ral cortical regions in which we observed interactions with CBF
(Rowe et al., 2007; Aizenstein et al., 2008; Villemagne et al., 2008).
Although conflicting reports exist regarding whether vascular risk
factors directly increase AD pathology (Chui et al., 2012), some
evidence links vascular dysfunction to the development of AD
pathology (Altman and Rutledge, 2010) and to the accumula-
tion of amyloid in particular (Craft, 2009; Zlokovic, 2011; Reed
et al., 2012). Indeed, the “two-hit vascular hypothesis” of AD
(Zlokovic, 2011) suggests that the presence of vascular risk factors
initiates a cascade of events involving BBB dysfunction, hypop-
erfusion, and impaired clearance and accumulation of amyloid,
thereby leading to dementia. Given that we did not collect mark-
ers of amyloid deposition or BBB integrity as part of this study,
we cannot directly examine these mechanisms. However, regard-
less of the precise mechanism, the present findings suggest that, as
non-demented older adults age, the presence of multiple vascular
risk factors may influence neuronal function within areas that are
vulnerable to early AD (Braskie et al., 2010; Bangen et al., 2012;
Beason-Held et al., 2012).
In contrast to some previously published studies (Beason-
Held et al., 2007; Bangen et al., 2009), we did not observe main
effects of age or vascular risk factors on CBF (cf., Glodzik et al.,
2011). However, these previous studies often focused on longitu-
dinal change rather than cross-sectional group differences in CBF
(Beason-Held et al., 2007, 2012), and compared young and old
adults (Bangen et al., 2009; Wierenga et al., 2013) rather than the
two groups of older adults included in the present study. WML
volume was not significantly correlated with CBF in the current
sample even though it is thought that hypoperfusion may lead to
the development of WML (Zlokovic, 2011). Furthermore, there
was no interaction between age and vascular risk on total WML
volume. Given that hypoperfusion and the development of WML
may be on a continuum, it is possible that older adults withmulti-
ple vascular risk factors who are demonstrating reduced CBF have
not yet developed increased WML volume but may do so over
time as chronic hypoperfusion worsens.
Several limitations should be considered when interpreting the
present findings and should be addressed in future studies. As is
commonly the case in neuroimaging studies, our sample size was
relatively small which may have attenuated our ability to detect
some group differences. It should be noted, however, that signif-
icant interactions between age and vascular risk burden on CBF
were found even in this small sample with relatively low vascular
risk burden. In addition, our sample was relatively well educated
and medically healthy which may reduce the generalizability of
the present results. Vascular risk factors in this study were cat-
egorized dichotomously as being either present or absent and
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vascular risk burden was characterized as high or low, rather than
considering vascular risk factors as continuous variables based on
risk factor severity. Further, given the cross-sectional nature of the
study, causality of the relationships among aging, vascular risk,
and CBF cannot be inferred. We identified hypertension based
in part on the use of anti-hypertensive medications, however, it
is unclear whether use of anti-hypertensive medications imparts
risk or is protective (Beishon et al., 2014). Limitations of ASLMRI
techniques more generally include relatively low signal-to-noise
ratios and reliance on assumptions in the perfusion quantifi-
cation (e.g., transit delay). The use of partial volume corrected
quantitative ASL data was a strength of the study. Despite these
limitations, the present study is one of the only attempts to assess
the interaction between vascular risk burden and advancing age
on ASL measures of CBF and cognition, making these findings a
potentially useful step toward elucidating the influence of vascu-
lar risk factors on CBF abnormalities among non-demented older
adults.
The present results add to a growing body of evidence
demonstrating the possible influence of vascular risk burden on
functional brain changes (CBF abnormalities) that may increase
risk of cognitive impairment and dementia (Tzourio et al.,
2001; Bangen et al., 2012). Among older adults with multiple
vascular risk factors, we found association between advancing
age and reduction in CBF in cortical regions implicated in
early AD. Evidence suggests that cognitive and brain changes
observed in very-old AD patients are less salient than those
seen in younger AD patients (Stricker et al., 2011). Thus, the
inclusion of additional markers may improve our ability to
predict progression to dementia in very-old adults (Stricker et al.,
2011). The present findings provide support for ASL MRI as a
candidate biomarker for detecting changes in the central nervous
system associated with vascular risk factors, particularly in older
adults with elevated vascular risk burden. Finally, the present
results highlight the potential utility of interventions designed to
treat reduced CBF in older adults who present with vascular risk
factors. Given that many vascular risk factors such as diabetes and
smoking can be treated, interventions designed to target vascular
risk factors in order to maintain CBF may represent important
opportunities for preventing or delaying the onset of cognitive
impairment and dementia (Gorelick et al., 2011; Qiu, 2012).
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